Research
Metabolic adaptation
Excess visceral abdominal fat (EVAF) can occur in people living with HIV-1 even with normal or mildly elevated body mass index (BMI).
Healthcare providers should assess visceral fat in PLWH regardless of BMI.
StrongSupportsmedium confidence
Excess visceral abdominal fat (EVAF) is a prevalent metabolic complication among people living with HIV-1 (PLWH), occurring even in individuals with normal or mildly elevated body mass index (BMI).
Why this rating
The abstract presents clinical case studies which provide strong evidence for the claims made.
Source
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists
Robin Beach et al. · Clinical Infectious Diseases · 2026
case_study · n=2Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →